Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma

Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma

Abstract Background and objectives The National Institute for Health and Care Excellence (England’s health technology assessment body) recommend the use of the average treatment effect (ATE) as an estimand for economic evaluations. However there is limited literature on methods to estimate the ATE,...

Full description

Saved in:
Bibliographic Details
Main Authors: Danilo Di Maio, S. A. Mitchell, S. Batson, E. Keeney, Howard H. Z. Thom
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Medical Research Methodology
Subjects:
Indirect treatment comparisons
Propensity score matching
Regression adjustment
Doubly robust
Counterfactual
ATE
Online Access:https://doi.org/10.1186/s12874-025-02456-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12874-025-02456-x

Similar Items